Quick Answer
STAAR SURGICAL CO reported Diluted EPS of $1.62 per share (loss) for fiscal year 2025.
STAAR SURGICAL CO Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.62 | -295.1% |
| 2024 | -$0.41 | -195.3% |
| 2023 | $0.43 | -46.2% |
| 2022 | $0.80 | +42.9% |
| 2021 | $0.56 | +366.7% |
| 2020 | $0.12 | -60.0% |
| 2019 | $0.30 | +172.7% |
| 2018 | $0.11 | +320.0% |
| 2017 | -$0.05 | +83.3% |
| 2016 | -$0.30 | -76.5% |
| 2015 | -$0.17 | +22.7% |
| 2014 | -$0.22 | -2300.0% |
| 2013 | $0.01 | +120.0% |
| 2012 | -$0.05 | -225.0% |
| 2011 | $0.04 | — |
| 2010 | $0.00 | +100.0% |
| 2009 | -$0.19 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.18 | -10.0% | +152.9% |
| June 30, 2025 | -$0.34 | -326.7% | +69.1% |
| March 31, 2025 | -$1.10 | -1471.4% | -650.0% |
| September 30, 2024 | $0.20 | +100.0% | +33.3% |
| June 30, 2024 | $0.15 | +25.0% | +314.3% |
| March 31, 2024 | -$0.07 | -240.0% | -170.0% |
| September 30, 2023 | $0.10 | -52.4% | -16.7% |
| June 30, 2023 | $0.12 | -53.8% | +140.0% |
- STAAR SURGICAL CO showed a decrease of -295.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, STAAR SURGICAL CO’s diluted eps has declined by 752.6% (from $0.19 per share (loss) to $1.62 per share (loss)).
- The most recent figure is from STAAR SURGICAL CO’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 3, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: